Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc CURLF


Primary Symbol: T.CURA

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > 5 Million American Nurses Get Behind Cannabis
View:
Post by blackspade799 on Jul 23, 2024 11:01pm

5 Million American Nurses Get Behind Cannabis

The American Nurses Association (ANA) has formally weighed in on the potential rescheduling of cannabis from Schedule I to III. ANA has members in all 50 states and U.S. territories, and represents the interests of the USA’s 5 million registered nurses.

In its letter of last week to Attorney General Merrick Garland, the ANA states cannabis meets all requirements of the currently accepted medical use test, justifying reclassification as a Schedule III drug under the Controlled Substances Act (CSA).

“The proposed reschedule will allow full research into the treatment benefits of cannabis and allow nurses and other health care practitioners to give the best care possible to their patients.”

But the ANA wants the DEA to go further, stating for advancement of public health and therapeutic access, cannabis should ultimately be removed from CSA scheduling altogether.

https://hempgazette.com/news/ana-cannabis-rescheduling-hg2260/

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities